Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00807586 · ClinicalTrials.gov registry record · Phase 4
Corticosteroid Pulse After Ablation
A Phase 4 study, sponsored by Minneapolis Heart Institute Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 119
- Enrollment target
NCT00807586: Completed Phase 4 study, sponsored by Minneapolis Heart Institute Foundation.
NCT00807586 is a Phase 4 study that has completed, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 119 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00807586, a Phase 4 study, has completed, sponsored by Minneapolis Heart Institute Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 119 participants
- Enrollment target
Study Summary
Radiofrequency ablation is an effective treatment for atrial fibrillation. However, about 20% of the time the atrial fibrillation recurs. Steroids given after the ablation may decrease inflammation caused by the ablation and thus improve healing and decrease the chance of recurrence of atrial fibrillation. In this study patients will be randomized to receive intravenous steroids or not immediately following the ablation.
Primary Outcome
Clinically significant atrial arrhythmias include ER, urgent care, or hospitalization for atrial fibrillation, cardioversion for atrial fibrillation, or atrial fibrillation requiring an increase in anti-arrhythmia medication
Interventions
- DRUG Placebo
- DRUG Solumedrol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2008-12 |
| Est. Completion | 2013-12 |
| Phase | Phase 4 |
What the finished NCT00807586 record still lists
NCT00807586 is an interventional study that assigns participants to a tested intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00807586 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00807586 about?
NCT00807586 is a clinical study titled "Corticosteroid Pulse After Ablation". Radiofrequency ablation is an effective treatment for atrial fibrillation. However, about 20% of the time the atrial fibrillation recurs. Steroids given after the ablation may decrease inflammation caused by the ablation and thus improve healing and decrease the chance of recurrence of atrial fibril...
What is the current status of trial NCT00807586?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 119 participants. The study started on 2008-12. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00807586?
The interventions under investigation include: Placebo (DRUG), Solumedrol (DRUG).
Who is sponsoring clinical trial NCT00807586?
This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00807586's enrollment target sits among peer trials
119 712th of 2000 higher than 1,288 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia